A Systematic Review of Risk Factors for Brain Metastases and Value of Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer |
Sun, Dian-Shui
(Cancer Center, the Second Hospital of Shandong University)
Hu, Li-Kuan (Cancer Center, Qilu Hospital of Shandong University) Cai, Ying (Medical Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine) Li, Xiao-Mei (Cancer Center, the Second Hospital of Shandong University) Ye, Lan (Cancer Center, the Second Hospital of Shandong University) Hou, Hua-Ying (Cancer Center, the Second Hospital of Shandong University) Wang, Cui-Hong (Cancer Center, the Second Hospital of Shandong University) Jiang, Yu-Hua (Cancer Center, the Second Hospital of Shandong University) |
1 | Albain KS, Rusch VW, Crowley JJ, et al (1995). Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer:mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol, 13, 1880-92. |
2 | Wang SY, Ye X, Ou W, et al (2009). Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer. Lung Cancer, 64, 238-43. DOI ScienceOn |
3 | Russell AH, Pajak TE, Selim HM, et al (1991). Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Rad Onc Biol Phys, 21, 637-43. DOI |
4 | Umsawasdi T, Valdivieso M, Chen TT, et al (1984). Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol, 2, 253-9. |
5 | Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al (1993). Treatment of single brain metastases: Radiotherapy alone or combined with neurosurgery? Ann Neurol, 33, 583-90. DOI ScienceOn |
6 | Zeng YD, Zhang L, Liao H, et al (2012). Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study. Asian Pac J Cancer Prev, 13, 909-14. 과학기술학회마을 DOI ScienceOn |
7 | Zhao J, Chen M, Zhong W, et al (2012). Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma. Clin Lung Cancer, 14, 188-93. |
8 | Pan M, Santamaria M, Wollman DB (2007). CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation. Nat Clin Pract Oncol, 4, 603-7. DOI ScienceOn |
9 | Lester JF, MacBeth FR, Coles B (2005). Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review. Int J Radiat Oncol Biol Phys, 63, 690-4. DOI ScienceOn |
10 | Mamon HJ, Yeap BY, Janne PA, et al (2005). High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol, 23, 1530-7. DOI ScienceOn |
11 | Miller TP, Crowley JJ. Mira J, et al (1998). A randomized trial of chemotherapy and radiotherapy for stage III non-small cell lung cancer. Cancer Therapeutics, 4, 229 -36. |
12 | Patchell RA, Tibbs PA, Walsh JW, et al (1990). A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med, 322, 494-500. DOI ScienceOn |
13 | Petrovic M, Ilic N, Loncarevic O, et al (2011). Risk factors for brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, radiotherapy and chemotherapy. Vojnosanit Pregl, 68, 643-9. DOI |
14 | Ding X, Dai H, Hui Z, et al (2012). Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer. Radiat Oncol, 7, 119. DOI |
15 | Pottgen C, Eberhardt W, Grannass A, et al (2007). Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. J Clin Oncol, 25, 4987-92. DOI ScienceOn |
16 | Robnett TJ, Machtay M, Stevenson JP, et al (2001). Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol, 19, 1344-9. |
17 | Gore EM, Bae K, Wong SJ, et al (2011). Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol, 29, 272-8. DOI ScienceOn |
18 | Gaspar L, Scott C, Rotman M, et al (1997). Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys, 37, 745-51. DOI ScienceOn |
19 | Gore E (2006). Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer. Clin Lung Cancer, 7, 276-8. DOI ScienceOn |
20 | Horinouchi H, Sekine I, Sumi M, et al (2012). Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factor. Cancer Sci, 103, 756-9. DOI ScienceOn |
21 | Hubbs JL, Boyd JA, Hollis D, et al (2010). Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer, 116, 5038-46. DOI ScienceOn |
22 | Andre F, Grunenwald D, Pujol JL, et al (2001). Patterns of relapse of N2 non-small-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer, 91, 2394-400. DOI |
23 | Keith B, Vincent M, Stitt L, et al (2002). Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer. Am J Clin Oncol, 25, 583-7. DOI ScienceOn |
24 | Lee DS, Kim YS, Jung SL, et al (2012). The relevance of serum carcinoembryonic antigen as an indicator of brain metastasis detection in advanced non-small cell lung cancer. Tumour Biol, 33, 1065-73. DOI ScienceOn |
25 | Bajard A, Westeel V, Dubiez A, et al (2004). Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer, 45, 317-23. DOI ScienceOn |
26 | Arrieta O, Saavedra-Perez D, Kuri R, et al (2009). Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis. BMC Cancer, 22, 119. |
27 | Auperin A, Arriagada R, Pignon JP, et al (1999). Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med, 341, 476-84. DOI ScienceOn |
28 | Ceresoli GL, Cappuzzo F, Gregorc V, et al (2004). Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Ann Oncol, 15, 1042-7. DOI ScienceOn |
29 | Ceresoli GL, Reni M, Chiesa G, et al (2002). Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer, 95, 605-12. DOI ScienceOn |
30 | Chen AM, Jahan TM, Jablons DM, et al (2007). Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer, 109, 1668-75. DOI ScienceOn |
31 | Cox JD, Stanley K, Petrovich Z, et al (1981). Cranial irradiation in cancer of the lung of all cell types. JAMA, 245, 469-72. DOI ScienceOn |
32 | Dimitropoulos C, Hillas G, Nikolakopoulou S, et al (2011). Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?. Cancer Manag Res, 3, 287-94. |